XRT secures new investors
Monday, 29 August, 2005
Unlisted imaging company XRT, an investee of BioTech Capital (ASX:BTC), has secured new investment funds from a syndicate of UK investors including an undisclosed institutional group.
Total funds to be invested in XRT equate to approximately £1.5 million (AUD$3.8million) at a pre-money valuation of £7.1 million.
Melbourne based XRT is planning to relocate its business development activities to the UK and will use the funds for the recruitment of a UK-based senior management team and to execute its business plan.
The University of Sydney formalises cervical cancer elimination partnership
The success of a cervical cancer elimination program has led to the signing of a memorandum of...
Noxopharm says paper reveals science behind its immune system platform
Clinical-stage Australian biotech company Noxopharm Limited says a Nature Immunology...
Neurosensing/neurostimulation implants session to be held on Monday
On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics...
